A sensitive, IL-2-independent, assay for IL-1

Area of Science:

• Immunology
• Cell Biology
• Biotechnology

Background:

• The standard thymocyte costimulator (LAF) assay for interleukin-1 (IL-1) titration suffers from low sensitivity and specificity.
• IL-1 assays are often confounded by the presence of interleukin-2 (IL-2) in biological samples.
• Existing methods lack the precision needed for accurate IL-1 quantification in complex biological fluids.

Purpose of the Study:

• To develop a novel, highly sensitive, and specific assay for interleukin-1 (IL-1) titration.
• To overcome the limitations of the traditional LAF assay, particularly its susceptibility to interference from IL-2.
• To enable reliable IL-1 measurement in biological fluids like lymphocyte culture supernatants.

Main Methods:

• Utilized the EL4-6.1 thymoma cell line, which differentiates and expresses IL-2 receptors upon IL-1 stimulation.
• Employed a suboptimal dose of phorbol diester as a costimulant.
• Developed flow cytometry and ELISA techniques for detecting IL-2 receptor expression as a readout for IL-1 presence.

Main Results:

• The new assay detects IL-1 at concentrations of 1-2 X 10(-4) ng/ml, a significant improvement over the LAF assay's 5 X 10(-2) ng/ml.
• The assay shows no interference from IL-2 up to 250 U/ml and exhibits 100-fold lower sensitivity to prostaglandin inhibition.
• Tumor necrosis factor alpha demonstrated only a weak costimulatory effect at very high doses.

Conclusions:

• The novel EL4-6.1 cell-based assay provides a highly sensitive and specific method for IL-1 titration.
• This assay effectively mitigates interference from common biological contaminants like IL-2 and prostaglandins.
• The developed assay is suitable for reliable IL-1 quantification in challenging biological samples, advancing cytokine research.